Industry Session
Vincent Jannin, n/a
Director, R&D
Capsugel France SAS / Lonza
Colmar, Alsace, France
Anette Müllertz, n/a (she/her/hers)
Professor
Pharmacy
University of Copenhagen
Copenhagen, Hovedstaden, Denmark
Joseph O’Shea
Cork University
This expert-led session explores the latest advancements in oral delivery systems for emerging drug modalities, with a particular focus on peptides and other complex molecules. Three leading scientists will share innovative strategies and real-world case studies that are helping to overcome barriers in oral bioavailability.
-Pr. Müllertz will kick-off the session with a deep dive into formulation options for peptides with lipid-based formulations, hydrophobic ion pairing (HIP), and permeation enhancers — highlighted through case studies such as exenatide and salmon calcitonin.
-Dr. O’Shea will follow with an in-depth look at the preclinical evaluation of proof-of-concept formulations in preclinical species like rats and pigs, with a focus on advantages and limitations of different models.
-Dr. Jannin will conclude the session by focusing on the advantages of enteric capsules to protect peptides and deliver high dose in the small intestine to favor absorption